NK1/NK3 Receptor Antagonists vs. HRT (Hormone Therapy) - for Hot Flashes

Navigating hot flashes during perimenopause and menopause can feel like being trapped in an inferno, except that fiery place is your own body.

Your face and chest become intensely warm within seconds, and sweat can appear out of nowhere. Then, to make matters even more confusing, you may feel chilled moments later. When they strike at night, they can disrupt your sleep and leave you feeling totally drained by the time your alarm goes off.

But you don't have to tolerate these oppressive symptoms; you have options to get relief. Hormone Replacement Therapy (HRT) remains the most effective treatment for hot flashes and night sweats for many women, but it’s no longer the only prescription option. Newer nonhormonal medications called NK3 and NK1/NK3 receptor antagonists target the brain pathways involved in hot flashes without replacing estrogen.

Both approaches can offer relief, but they work differently. For instance, since an NK3 receptor antagonist is nonhormonal, some patients who are ineligible for HRT due to certain health conditions may prefer them for managing hot flashes and night sweats. Other patients with several menopausal symptoms, like brain fog, joint pain, trouble with sleep or irritability, may prefer to start with HRT as it can help with more than just hot flashes. 

Understanding how each one works can help you have a more informed conversation with your menopause clinician about which treatment may be right for you.

Why Hot Flashes Happen

During perimenopause, your estrogen levels fluctuate up and down rather than declining steadily and consistently. These hormonal shifts affect your hypothalamus, or the part of your brain that helps regulate your body temperature.

This means the range of temperatures your body considers comfortable, sometimes called the thermoneutral zone, narrows. So, a small temperature change may prompt your body to overcorrect by dilating blood vessels and producing sweat. Once the heat passes, you may feel instantly cold or experience chills.

Hot flashes can begin up to 10 years before your last period. Some women experience an occasional uptick in body temperature, while others have frequent, intense episodes that affect their sleep, concentration, mood, and overall quality of life.

How NK3 and NK1/NK3 Antagonists Work

NK antagonists are nonhormonal medications that target the brain’s temperature-control system rather than replacing estrogen.

During perimenopause and menopause, fluctuating estrogen levels can make the hypothalamus more sensitive. NK antagonists block some of the chemical signals involved in this process, helping calm the pathway that triggers hot flashes.

Fezolinetant, sold under the brand name Veozah, became the first FDA-approved NK3 receptor antagonist for moderate to severe menopausal hot flashes in 2023. Elinzanetant, sold as Lynkuet, is a dual NK1/NK3 receptor antagonist that received FDA approval in October 2025.

Unlike older nonhormonal treatments such as certain antidepressants or gabapentin (a medication that helps prevent and control partial seizures), these medications were specifically developed to treat menopausal hot flashes. In clinical trials, some women taking fezolinetant noticed improvement within the first week. Elinzanetant also reduced hot flash frequency and severity while improving sleep and menopause-related quality of life. 

Why HRT Remains the Gold Standard

Unlike NK antagonists, HRT addresses one of the underlying drivers of menopause symptoms by replacing some of the estrogen your body is no longer consistently producing. It targets the root problem, which is why it remains the most effective treatment for hot flashes and night sweats.

HRT may also improve other symptoms that NK antagonists don’t directly treat, such as vaginal dryness, painful sex, and bone loss. Some women also notice improvements in sleep, joint discomfort, and mood, especially when those symptoms are linked to hormonal changes.

Systemic estrogen is available in several forms, including patches, gels, sprays, and pills. Women who still have a uterus generally take progesterone alongside estrogen to help protect their uterine lining. Women who’ve had a hysterectomy, on the other hand, can use estrogen alone. 

Whether HRT is the right choice for you depends on several factors, including your age, where you’re at in the menopause transition, your symptoms, your medical history, and your treatment goals. A menopause-specialized doctor can help you weigh the benefits and risks to determine the best approach for you.

How Do NK Antagonists Compare With HRT?

Research suggests that Fezolinetant can offer meaningful hot flash relief and may even be comparable to some hormone therapies. It also appears to reduce hot flashes more effectively than several older nonhormonal medications, but of course, everyone’s response is different.

The key difference between NK antagonists and MHT may be the range of symptoms each option can address. For instance, if your menopausal symptoms are hot flashes and night sweats, an NK antagonist may provide targeted relief without hormones. 

But if you’re also dealing with vaginal symptoms, bone-health concerns, or several menopause symptoms at once, MHT can offer more benefits than a nonhormonal option.

It’s important to remember that neither treatment works the same for everyone. Some women notice positive changes within the first one to two weeks, while others need more time. Some may even need to adjust their treatment plan a few times before finding their sweet spot. 

Who May Prefer a Nonhormonal Treatment?

Some women cannot take systemic estrogen because of their medical history. Others simply prefer a hormone-free option. In both of these scenarios, an NK antagonist may be the best option for you.

For example, if you have a history of certain estrogen-sensitive cancers, unexplained vaginal bleeding, blood clots, stroke, or severe liver disease, HRT may not be the most appropriate treatment for you. These conditions don’t all carry the same level of risk, though, so your clinician will evaluate your eligibility based on your individual health history.

Older nonhormonal medications still have a role, too. Low-dose paroxetine is FDA-approved for menopausal hot flashes, while some SSRIs, SNRIs, gabapentin, and oxybutynin are prescribed off-label. The right choice may depend on whether you also need help with mood, sleep, pain, or another health concern.

Non-hormonal

Paroxetine

$34.99

1-month supply

Best for non-hormonal relief from hot flashes and night sweats

Start Now

Potential Side Effects 

Like any prescription treatment, HRT comes with some potential risks. Those risks vary based on factors such as your age, health history, when you start treatment, the dose, and the type of hormone therapy you use.

Potential risks for some women include blood clots, stroke, gallbladder disease, and breast cancer, depending on the type of hormone therapy used and your health history. Transdermal estrogen, which is absorbed directly through your skin (patch, spray or gel), may be a better option for some women because it doesn’t appear to carry the same blood clot risks as oral estrogen.

While NK antagonists avoid risks directly related to taking estrogen, that doesn’t mean that nonhormonal options are entirely risk-free. For example, Fezolinetant carries an FDA boxed warning about the rare possibility of serious liver injury. That’s the main reason why liver blood tests are required before treatment and periodically after starting it. (Note: Women should also contact their clinician promptly if they develop symptoms such as yellowing of the skin or eyes, dark urine, severe fatigue, nausea, vomiting, or upper abdominal pain.)

Elinzanetant has its own side effects and prescribing considerations, including possible headache, fatigue, or drowsiness. It’s a bedtime medication, so if you take other medicines that can cause drowsiness, your doctor can help make sure the combination is appropriate for you.

Can You Use an NK Antagonist With HRT?

Right now, there isn’t enough research to suggest taking an NK antagonist and systemic HRT together is a good idea.  The treatment options are considered to be alternatives not complementary at this time. Currently, there is no data on taking both treatments at the same time. Because both treatments are designed to reduce hot flashes and night sweats, most women start with one approach to see how well it works. There are several ways to address hot flashes and overtreating is not a good option. You can always try a treatment and if your symptoms are persistent, your doctor can help to make adjustments. There are many ways to treat hot flashes, and more treatment isn’t always better. The goal is to find the right approach for your individual symptoms and needs.

At the same time, that doesn’t mean every menopause symptom has to be treated with the same medication. For example, you may take an NK antagonist for hot flashes but still use low-dose vaginal estrogen to help relieve vaginal dryness, painful sex, or recurrent urinary tract infections. Because vaginal estrogen stays mostly localized, it exposes the rest of the body to much lower hormone levels than systemic HRT options.

Estradiol Vaginal Cream

$119.97

3-month supply

Effective relief for vaginal dryness, itching, burning and the prevention of frequent UTIs.

Start Now

Your treatment plan can also change over time. What works during the early stages of perimenopause may not work for you five years down the line and that’s okay. Your menopause care plan is meant to be adjusted. 

How to Decide Which Treatment Is Right for You

The most appropriate treatment depends on your hot flash severity, medical history, where you’re at in the menopause transition, and whether you’re navigating other bothersome menopausal symptoms. 

A menopause-specialized doctor can help you weigh the benefits, risks, and monitoring needs of MHT and nonhormonal options like NK1 and NK3 antagonists based on your health history and goals. Keep your care team in the loop, especially if your symptoms change at all during your treatment.

Frequently Asked Questions

How do NK receptor antagonists differ from Hormone Replacement Therapy (HRT)?

NK receptor antagonists are nonhormonal medications that target the hypothalamus—the brain's temperature-control center—to block the chemical signals that trigger hot flashes. HRT, on the other hand, replaces the estrogen the body is no longer consistently producing. While NK antagonists provide targeted relief for hot flashes and night sweats without using hormones, HRT can address a broader range of menopausal symptoms, including vaginal dryness, painful sex, joint discomfort, and bone loss.

Who should consider a nonhormonal treatment like an NK antagonist over HRT?

Nonhormonal options are ideal for individuals who prefer a hormone-free approach or who cannot safely take systemic estrogen. HRT may not be appropriate for those with a personal medical history of estrogen-sensitive cancers, unexplained vaginal bleeding, blood clots, stroke, or severe liver disease.

Can you take an NK antagonist and HRT at the same time?

Combining systemic HRT and an NK antagonist is currently not recommended, as there is no safety or efficacy data on using both simultaneously, and both primary treatments target the same symptoms. However, localized low-dose vaginal estrogen can still be used alongside an NK antagonist to manage vaginal dryness or recurrent urinary tract infections, as localized estrogen exposes the rest of the body to minimal hormone levels.